AJR Get Involved! Join ARRS Today
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khandani, A. H.
Right arrow Articles by Mauro, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khandani, A. H.
Right arrow Articles by Mauro, M. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.2126
AJR 2007; 189:1199-1202
© American Roentgen Ray Society

Clinical Observations

A Pilot Study of Early 18F-FDG PET to Evaluate the Effectiveness of Radiofrequency Ablation of Liver Metastases

Amir H. Khandani1,2, Benjamin F. Calvo2,3, Bert H. O'Neil2,4, Jennifer Jorgenson1,5 and Matthew A. Mauro2,5

1 Section of Nuclear Medicine, Department of Radiology, UNC School of Medicine, CB #7510, Chapel Hill, NC 27599-7510.
2 UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
3 Division of Surgical Oncology, Department of Surgery, UNC School of Medicine, Chapel Hill, NC.
4 Division of Hematology–Oncology, Department of Medicine, UNC School of Medicine, Chapel Hill, NC.
5 Section of Vascular and Interventional Radiology, Department of Radiology, UNC School of Medicine, Chapel Hill, NC.

OBJECTIVE. The objective of our study was to collect pilot data about the use of FDG PET within hours after radiofrequency ablation (RFA) of liver metastases.

CONCLUSION. Total photopenia on early PET can potentially be regarded as a macroscopic tumor-free margin; focal uptake can be regarded as macroscopic residual tumor.

Keywords: FDG PET • liver cancer • liver metastasis • metastases • oncologic imaging • radiofrequency ablation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.